297 related articles for article (PubMed ID: 27836336)
61. Comparing progression biomarkers in clinical trials of early Alzheimer's disease.
Cullen NC; Zetterberg H; Insel PS; Olsson B; Andreasson U; ; Blennow K; Hansson O; Mattsson-Carlgren N
Ann Clin Transl Neurol; 2020 Sep; 7(9):1661-1673. PubMed ID: 32779869
[TBL] [Abstract][Full Text] [Related]
62. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
63. Anterior and posterior MTL networks in aging and MCI.
Das SR; Pluta J; Mancuso L; Kliot D; Yushkevich PA; Wolk DA
Neurobiol Aging; 2015 Jan; 36 Suppl 1(0 1):S141-50, S150.e1. PubMed ID: 25444600
[TBL] [Abstract][Full Text] [Related]
64. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
Schmand B; Huizenga HM; van Gool WA
Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
[TBL] [Abstract][Full Text] [Related]
65. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease.
Westman E; Cavallin L; Muehlboeck JS; Zhang Y; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Simmons A; Wahlund LO;
PLoS One; 2011; 6(7):e22506. PubMed ID: 21811624
[TBL] [Abstract][Full Text] [Related]
66. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
67. Medial temporal lobe high resolution magnetic resonance images for the early diagnosis of Alzheimer's disease.
Brun F; Sensi F; Quartulli R; Rei L; Grucka A; Mancarella V; Chincarini A; Ukmar M; Accardo A; Longo R
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():4274-7. PubMed ID: 26737239
[TBL] [Abstract][Full Text] [Related]
68. Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area.
Dickerson BC; Feczko E; Augustinack JC; Pacheco J; Morris JC; Fischl B; Buckner RL
Neurobiol Aging; 2009 Mar; 30(3):432-40. PubMed ID: 17869384
[TBL] [Abstract][Full Text] [Related]
69. The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease.
Davis PC; Gearing M; Gray L; Mirra SS; Morris JC; Edland SD; Lin T; Heyman A
Neurology; 1995 Jan; 45(1):178-9. PubMed ID: 7824112
[TBL] [Abstract][Full Text] [Related]
70. Short-Term Memory Depends on Dissociable Medial Temporal Lobe Regions in Amnestic Mild Cognitive Impairment.
Das SR; Mancuso L; Olson IR; Arnold SE; Wolk DA
Cereb Cortex; 2016 May; 26(5):2006-17. PubMed ID: 25725042
[TBL] [Abstract][Full Text] [Related]
71. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
72. Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex.
Xie L; Das SR; Wisse LEM; Ittyerah R; Yushkevich PA; Wolk DA;
J Alzheimers Dis; 2018; 62(1):85-92. PubMed ID: 29439350
[TBL] [Abstract][Full Text] [Related]
73. Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
Sheng C; Xia M; Yu H; Huang Y; Lu Y; Liu F; He Y; Han Y
PLoS One; 2017; 12(6):e0179823. PubMed ID: 28650994
[TBL] [Abstract][Full Text] [Related]
74. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
[TBL] [Abstract][Full Text] [Related]
75. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
[TBL] [Abstract][Full Text] [Related]
76. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
[TBL] [Abstract][Full Text] [Related]
77. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
78. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
79. New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements.
Clerx L; Visser PJ; Verhey F; Aalten P
J Alzheimers Dis; 2012; 29(2):405-29. PubMed ID: 22330833
[TBL] [Abstract][Full Text] [Related]
80. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.
Pereira JB; Cavallin L; Spulber G; Aguilar C; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Aarsland D; Lovestone S; Simmons A; Wahlund LO; Westman E;
J Intern Med; 2014 Mar; 275(3):317-30. PubMed ID: 24118559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
